Pliant TherapeuticsInc Ownership
| PLRX Stock | USD 12.13 0.04 0.33% |
Shares in Circulation | First Issued 2019-03-31 | Previous Quarter 59 M | Current Value 60 M | Avarage Shares Outstanding 32.2 M | Quarterly Volatility 21.3 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Pliant |
Pliant Stock Ownership Analysis
About 94.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.8. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pliant TherapeuticsInc recorded a loss per share of 2.86. The entity had not issued any dividends in recent years. Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California. Pliant Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 110 people. To find out more about Pliant TherapeuticsInc contact MBA MD at 650 481 6770 or learn more at https://pliantrx.com.Besides selling stocks to institutional investors, Pliant TherapeuticsInc also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Pliant TherapeuticsInc's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Pliant TherapeuticsInc's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Pliant TherapeuticsInc Quarterly Liabilities And Stockholders Equity |
|
Pliant TherapeuticsInc Insider Trades History
About 6.0% of Pliant TherapeuticsInc are currently held by insiders. Unlike Pliant TherapeuticsInc's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Pliant TherapeuticsInc's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Pliant TherapeuticsInc's insider trades
Pliant Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Pliant TherapeuticsInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pliant TherapeuticsInc backward and forwards among themselves. Pliant TherapeuticsInc's institutional investor refers to the entity that pools money to purchase Pliant TherapeuticsInc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Franklin Resources Inc | 2023-12-31 | 1.6 M | Casdin Capital, Llc | 2023-12-31 | 1.6 M | Capital Research & Mgmt Co - Division 3 | 2024-03-31 | 1.4 M | State Street Corporation | 2023-12-31 | 1.3 M | Pictet Asset Manangement Sa | 2023-12-31 | 1.3 M | Ra Capital Management, Llc | 2023-12-31 | 1.3 M | Geode Capital Management, Llc | 2023-12-31 | 1.2 M | Granahan Investment Management Inc.. | 2023-12-31 | 1.2 M | Deutsche Bank Ag | 2023-12-31 | 985 K | Deep Track Capital, Lp | 2023-12-31 | 5.8 M | Blackrock Inc | 2023-12-31 | 4.8 M |
Pliant TherapeuticsInc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pliant TherapeuticsInc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pliant TherapeuticsInc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pliant TherapeuticsInc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Pliant TherapeuticsInc Corporate Filings
8K | 14th of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 6th of May 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 22nd of April 2024 Other Reports | ViewVerify | |
13A | 14th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pliant TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pliant TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pliant Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pliant Therapeuticsinc Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pliant TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pliant Stock please use our How to Invest in Pliant TherapeuticsInc guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Pliant Stock analysis
When running Pliant TherapeuticsInc's price analysis, check to measure Pliant TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant TherapeuticsInc is operating at the current time. Most of Pliant TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Pliant TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant TherapeuticsInc's price. Additionally, you may evaluate how the addition of Pliant TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is Pliant TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pliant TherapeuticsInc. If investors know Pliant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pliant TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.86) | Revenue Per Share 0.004 | Quarterly Revenue Growth (1.00) | Return On Assets (0.22) | Return On Equity (0.34) |
The market value of Pliant TherapeuticsInc is measured differently than its book value, which is the value of Pliant that is recorded on the company's balance sheet. Investors also form their own opinion of Pliant TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Pliant TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pliant TherapeuticsInc's market value can be influenced by many factors that don't directly affect Pliant TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pliant TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pliant TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pliant TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.